ClinicalTrials.gg
Not yet recruitingNCT06111066Updated Nov 1, 2023

Vitamin D Levels in Neonatal Umbilical Cord Blood: Factors and Prognostic Analysis

An observational study in Vitamin d Deficiency, sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Not yet recruiting at 1 site in China. Open to participants aged 1 Day to 5 Years. Per ClinicalTrials.gov, last updated 2023-11-01.

Sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
186
Ages
1 Day to 5 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Vitamin D Deficiency with a site in China — 3 open to participants now, 3 under way, none of them phase 3. Vitamin D Deficiency · China.

Planned enrollment
6th of 10
186 · median 193
Started
2024
the only one that year
Observational
10 of 28
2 open now
Registered
27th of 28
by date

Among the 28 studies in Vitamin D Deficiency with a site in China, this one is the 6th largest by planned enrollment of the 10 observational ones that give a count, is the only one that started in 2024, is one of 10 observational ones, and was the 27th registered.

Vitamin D Deficiency

800 studies on the registry are indexed under Vitamin D Deficiency; 60 are open to participants now.

Browse Vitamin D Deficiency studies →

Open to participants now

3 of the 28 studies in Vitamin D Deficiency with a site in China are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 37 Vitamin D Deficiency studies recruiting now, 16 (43%) set no upper age limit and 18 (49%) stop at 75 or younger; 10 take children under 18; 11 take healthy volunteers.

This study: 1 Day to 5 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Vitamin D Deficiency with a site in China, or all of them as a file.
02

Study summary

This study is a retrospective-prospective cohort study that investigates the factors influencing neonatal umbilical cord blood 25(OH)D levels, and the impact of exposure to low intrauterine 25(OH)D levels on neonatal prognosis. Newborns born in Sun Yat-sen Memorial Hospital of Sun Yat-sen University from August 2023 to August 2024 were selected. 2ml of umbilical cord blood was collected to test serum 25(OH)D levels. Based on the umbilical cord blood 25(OH)D levels, newborns were divided into three groups: vitamin D deficiency (\<30nmol/L), insufficiency (30\~50nmol/L), and sufficiency (>50\~250nmol/L). Factors influencing neonatal vitamin D levels at birth were investigated by reviewing medical records, questionnaire collection, phone interviews, etc., collecting data on basic neonatal information, maternal information, complications during pregnancy, prenatal biochemical test results, medication history during pregnancy, lifestyle habits during pregnancy, and vitamin D supplementation status. Phone follow-ups on the health of the newborns during their hospital stay and at 1 month and 2 months after discharge were conducted to investigate the impact of exposure to low intrauterine 25(OH)D levels on neonatal prognosis, providing a theoretical basis for early intervention in high-risk pregnant women and early identification of high-risk groups with vitamin D deficiency or insufficiency among newborns.

Miscarriages prevention is a major feature of our hospital's obstetrics department. Many pregnant women who are hospitalized and give birth at our hospital have a history of fetus protection. Choosing pregnant women and newborns from our hospital's obstetrics department as research subjects is conducive to exploring the impact of specific diseases and medication histories on neonatal vitamin D deficiency, which is an innovative aspect of this study.

03

Conditions studied

  • Vitamin d Deficiency

Browse trials for

Keywords

  • vitamin D
  • neonatal umbilical cord blood
  • influence factors
  • prognosis
04

Who can participate

Ages eligible
1 Day to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Selected newborns and their mothers who were born at Sun Yat-sen Memorial Hospital of Sun Yat-sen University starting from September 2023.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Newborns delivered in Sun Yat-sen Memorial Hospital's obstetrics department.
  • Relatives agree to use clinically discarded specimens for research and have signed a consent form.

Exclusion criteria

Exclusion Criteria:

  • Newborns with genetic mutations or congenital malformations.
  • Patients who died before discharge.
  • Pregnant women with conditions like chylous diarrhea, inflammatory bowel disease, and other chronic digestive system diseases.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
186 participants (estimated)
Patient registry
No

Groups and cohorts

  • vitamin D deficiency

    The umbilical cord blood 25(OH)D levels: \<30nmol/L

  • vitamin D insufficiency

    The umbilical cord blood 25(OH)D levels: 30\~50nmol/L

  • vitamin D sufficiency

    The umbilical cord blood 25(OH)D levels: \>50\~250nmol/L

06

What researchers measure

Primary outcomes

  1. Maternal use of vitamin D supplements.

    Investigating the situation of mothers taking vitamin D supplements during pregnancy through questionnaires and telephone interviews. This includes when they started taking them during pregnancy(weeks of gestation), the frequency of consumption(how many days a week), and the dosage taken each time(IU).

    Time frame: 2024.01-2029.12

  2. Maternal sunlight exposure.

    Investigating the conditions of sunlight exposure during pregnancy through questionnaires and telephone interviews. Including ethnicity, skin color, long-term residence during pregnancy, outdoor activity time (how many hours per day), and whether sun protection measures are used when going out (such as sunscreen, umbrellas, clothing)

    Time frame: 2024.01-2029.12

Secondary outcomes

  1. Maternal education status.

    Education levels are divided into two categories based on the highest level of education attained. The first category is 'below bachelor's degree,' which includes no formal education, elementary school, junior high school, high school, and vocational/technical education. The second category is 'bachelor's degree and above,' which includes bachelor's degrees, master's degrees, and doctoral degrees.

    Time frame: 2024.01-2029.12

  2. Maternal weight.

    Calculated by maternal pre-pregnancy BMI, referring to the weight (kg) within one week before delivery, divided by the square of height (m). And the maternal weight gain during pregnancy (kg).

    Time frame: 2024.01-2029.12

  3. Pregnancy complications.

    Pregnancy complications refer to health problems that occur during pregnancy. Including gestational diabetes, hypertensive disease in pregnancy, preeclampsia, intrauterine growth restriction (IUGR), and so on.

    Time frame: 2024.01-2029.12

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2024; primary completion for Jan 2026, 24 months later.

Of 61 non-industry observational studies under Vitamin D Deficiency, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 40. This study's planned 24 months is above that.

Counting every sponsor, half of 62 studies reached it within 19 months; a quarter within 9 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 9, 2023
First posted
Nov 1, 2023
StartEst.
Jan 1, 2024
Primary completionEst.
Jan 1, 2026
CompletionEst.
Dec 30, 2029
Last update
Nov 1, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06111066
Responsible party
Sponsor
First posted
Nov 1, 2023
Start date
Jan 1, 2024 (estimated)
Primary completion
Jan 1, 2026 (estimated)
Completion
Dec 30, 2029 (estimated)
Last update
Nov 1, 2023

Study contacts

Ouyang Ying, Prof.
Contact
ouyy@mail.sysu.edu.cn
+86 13925131189
Xie Xinyi, BS
Contact
tsesumyee1997@163.com
+86 15636110916
Ouyang Ying, Prof.
study director · Sun Yat-sen Memorial Hospital,Sun Yat-sen University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion